Central Vietnam Metal Corporation (HNX:KMT)

Intercept Pharmaceuticals Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2019	FY 2018	FY 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2016
Cash & Equivalents	5,157	10,275	2,467	23,475	34,493	16,376
Short-Term Investments	2,347	2,047	1,000	-	-	-
Trading Asset Securities	6,500	6,300	-	-	-	-
Cash & Short-Term Investments	14,004	18,622	3,467	23,475	34,493	16,376
Cash Growth	303.93%	437.12%	-85.23%	-31.94%	110.63%	-31.34%
Accounts Receivable	757,149	632,764	618,223	447,132	465,953	308,021
Other Receivables	10,190	6,362	5,762	22,240	2,726	6,713
Receivables	767,339	639,126	623,985	469,371	468,679	314,734
Inventory	50,299	41,308	57,648	76,147	94,281	59,889
Prepaid Expenses	352.13	98.13	164.51	342.39	45.81	199.86
Other Current Assets	42,854	19,399	40,418	30,131	38,578	48,524
Total Current Assets	874,848	718,554	725,683	599,467	636,077	439,724
Property, Plant & Equipment	14,658	14,986	14,754	19,892	21,095	19,910
Long-Term Investments	-	-	-	-	24,000	21,618
Other Intangible Assets	33,435	33,448	33,501	33,692	34,196	34,744
Other Long-Term Assets	26,007	26,314	27,231	27,553	21,522	17,547
Total Assets	948,949	793,301	801,169	680,603	736,890	533,542
Accounts Payable	53,991	1,766	51,707	102,719	93,855	72,528
Accrued Expenses	2,425	4,329	4,052	5,693	8,007	5,931
Short-Term Debt	674,298	583,208	581,022	435,646	500,227	329,308
Current Income Taxes Payable	990.19	2,862	1,966	121.86	110.77	114.03
Current Unearned Revenue	880.8	893.45	694.24	689.2	-	65.33
Other Current Liabilities	75,636	61,540	27,041	8,569	7,522	6,265
Total Current Liabilities	808,221	654,598	666,483	553,438	609,722	414,211
Total Liabilities	808,221	654,598	666,483	553,438	609,722	414,211
Common Stock	98,466	98,466	98,466	98,466	98,466	98,466
Additional Paid-In Capital	300.35	300.35	300.35	300.35	300.35	300.35
Retained Earnings	40,471	38,446	34,430	26,908	26,911	19,074
Comprehensive Income & Other	1,491	1,491	1,491	1,491	1,491	1,491
Shareholders' Equity	140,728	138,703	134,687	127,165	127,168	119,331
Total Liabilities & Equity	948,949	793,301	801,169	680,603	736,890	533,542
Total Debt	674,298	583,208	581,022	435,646	500,227	329,308
Net Cash (Debt)	-660,293	-564,586	-577,555	-412,171	-465,734	-312,932
Net Cash Per Share	-67058.28	-57338.40	-58655.45	-	-	-
Filing Date Shares Outstanding	9.85	9.85	9.85	-	-	-
Total Common Shares Outstanding	9.85	9.85	9.85	-	-	-
Working Capital	66,627	63,956	59,200	46,029	26,355	25,513
Book Value Per Share	14292.05	14086.43	13678.53	-	-	-
Tangible Book Value	107,293	105,255	101,185	93,473	92,972	84,588
Tangible Book Value Per Share	10896.45	10689.49	10276.21	-	-	-
Buildings	23,101	23,101	23,101	-	-	-
Machinery	8,254	8,254	7,612	-	-	-
Construction In Progress	135.29	135.29	135.29	2,607	1,776	1,760

Source: S&P Global Market Intelligence. Standard template. Financial Sources.